These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 26874038)

  • 1. Values of osteoprotegerin in aortic valve tissue in patients with significant aortic stenosis depend on the existence of concomitant coronary artery disease.
    Fojt R; Pirk J; Kamenický P; Karpíšek M; Straka Z; Malý M; Moťovská Z
    Cardiovasc Pathol; 2016; 25(3):181-184. PubMed ID: 26874038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves.
    Lis GJ; Czubek U; Jasek-Gajda E; Łoboda A; Dulak J; Nessler J; Kapelak B; Sadowski J; Litwin JA
    Pol Arch Med Wewn; 2016; 126(3):149-58. PubMed ID: 27003233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves.
    Steinmetz M; Skowasch D; Wernert N; Welsch U; Preusse CJ; Welz A; Nickenig G; Bauriedel G
    J Heart Valve Dis; 2008 Mar; 17(2):187-93. PubMed ID: 18512489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification.
    Kaden JJ; Bickelhaupt S; Grobholz R; Haase KK; Sarikoç A; Kiliç R; Brueckmann M; Lang S; Zahn I; Vahl C; Hagl S; Dempfle CE; Borggrefe M
    J Mol Cell Cardiol; 2004 Jan; 36(1):57-66. PubMed ID: 14734048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of osteoprotegerin and soluble ligand of receptor of kappa-B transcription factor activator in the calcification of aortic valve].
    Voronkina IV; Irtyuga OB; Smagina LV; Adamova PE; Zhiduleva EV; Malashicheva AB; Sibagatullina YS; Kruk LP; Gordeev ML; Moiseeva OM
    Biomed Khim; 2019 Jan; 65(1):57-62. PubMed ID: 30816098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Dickkopf-1 signaling and calcium deposition in aortic valve are significantly related to the presence of concomitant coronary atherosclerosis in patients with symptomatic calcified aortic stenosis.
    Motovska Z; Vichova T; Doktorova M; Labos M; Maly M; Widimsky P
    J Transl Med; 2015 Feb; 13():63. PubMed ID: 25889943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Osteoprotectin (OPG)/Receptor Activator of Nuclear Factor-
    Luo W; Song Y; Wang J; Yang X; Li Z; Cong H
    Biomed Res Int; 2022; 2022():1592576. PubMed ID: 35993046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum osteoprotegerin is associated with decreased osteoclastic differentiation in stenotic aortic valves.
    Lis GJ; Czubek U; Jasinska M; Jasek E; Loboda A; Dulak J; Nessler J; Sadowski J; Litwin JA
    J Physiol Pharmacol; 2014 Jun; 65(3):377-82. PubMed ID: 24930509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification.
    Lommi JI; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Kupari M; Helske S
    Atherosclerosis; 2011 Dec; 219(2):538-44. PubMed ID: 21917259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valvular osteoclasts in calcification and aortic valve stenosis severity.
    Nagy E; Eriksson P; Yousry M; Caidahl K; Ingelsson E; Hansson GK; Franco-Cereceda A; Bäck M
    Int J Cardiol; 2013 Oct; 168(3):2264-71. PubMed ID: 23452891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice.
    Weiss RM; Lund DD; Chu Y; Brooks RM; Zimmerman KA; El Accaoui R; Davis MK; Hajj GP; Zimmerman MB; Heistad DD
    PLoS One; 2013; 8(6):e65201. PubMed ID: 23762316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of osteopontin, and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis: association with HDL subclasses.
    Luna-Luna M; Cruz-Robles D; Ávila-Vanzzini N; Herrera-Alarcón V; Martínez-Reding J; Criales-Vera S; Sandoval-Zárate J; Vargas-Barrón J; Martínez-Sánchez C; Tovar-Palacio AR; Fragoso JM; Carreón-Torres E; Vargas-Alarcón G; Pérez-Méndez Ó
    Lipids Health Dis; 2017 Aug; 16(1):156. PubMed ID: 28821297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
    Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease.
    Adamczyk T; Mizia-Stec K; Mizia M; Haberka M; Chmiel A; Chudek J; Gąsior Z
    Pol Arch Med Wewn; 2012; 122(1-2):14-21. PubMed ID: 22237719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signalling.
    Toshima T; Watanabe T; Narumi T; Otaki Y; Shishido T; Aono T; Goto J; Watanabe K; Sugai T; Takahashi T; Yokoyama M; Kinoshita D; Tamura H; Kato S; Nishiyama S; Arimoto T; Takahashi H; Miyamoto T; Sadahiro M; Watanabe M
    Cardiovasc Res; 2020 Apr; 116(5):983-994. PubMed ID: 31393559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concentration of osteoprotegerin and RANKL in blood serum of patients with aortic stenosis].
    Irtiuga OB; Zhiduleva EV; Dubrovskaia OB; Moiseeva OM
    Kardiologiia; 2014; 54(6):44-8. PubMed ID: 25178077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic root, not valve, calcification correlates with coronary artery calcification in patients with severe aortic stenosis: A two-center study.
    Henein M; Hällgren P; Holmgren A; Sörensen K; Ibrahimi P; Kofoed KF; Larsen LH; Hassager C
    Atherosclerosis; 2015 Dec; 243(2):631-7. PubMed ID: 26551591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic characteristics of patients undergoing aortic valve replacement for stenosis: relation to valve morphology.
    Davies MJ; Treasure T; Parker DJ
    Heart; 1996 Feb; 75(2):174-8. PubMed ID: 8673757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elevated HDL is the main negative risk factor for coronary artery disease in the elderly patient with calcific aortic valve disease].
    Bordalo AD; Nobre AL; Dantas M; Cravino J
    Rev Port Cardiol; 2012 Jun; 31(6):415-24. PubMed ID: 22609029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
    Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
    Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.